Влияние ингибиторов фосфодиэстеразы-5 на альвеолярный кровоток легочного трансплантата
Аннотация
Об авторах
П. К. Яблонский
ФГБУ «Санкт-Петербургский НИИ фтизиопульмонологии» Министерства здравоохранения РФ, Санкт-Петербург
Россия
Россия
О. Н. Резник
ГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Министерства здравоохранения РФ, Санкт-Петербург
Россия
Россия
А. Е. Скворцов
ГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Министерства здравоохранения РФ, Санкт-Петербург
Россия
Россия
В. Е. Милехин
ФГБУ «Санкт-Петербургский НИИ фтизиопульмонологии» Министерства здравоохранения РФ, Санкт-Петербург,
Россия
Россия
Список литературы
1. Первая трансплантация легких в НИИ скорой помощи им. Н.В. Склифосовского / М.Ш. Хубутия [и др.] // Трансплантология. – 2011. – № 2–3. – С. 5–9.
2. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart – Lung Transplant Report – 2011 / J.D. Christie [et al.] // J. Heart Lung. Transplant. – 2011. – Vol. 30, N 10. – P. 1104–1122.
3. Трансплантология: Руководство для врачей / Под ред. В.И. Шумакова. – М.: МИА, 2006.– 544 c.
4. Clinical risk factors for primary graft dysfunction after lung transplantation / J.M. Diamond [et al.] // Am. J. Respir. Crit. Care Med. – 2013. – Vol. 187, N 5. – P. 527–534.
5. Ahmad, S. Pulmonary complications of lung transplantation / S. Ahmad, O.A. Shlobin, S.D. Nathan // Chest. – 2011. – Vol. 139, N 2. – P. 402–411.
6. The impact of prolonged cold preservation on the graft function and gene expression levels in an experimental lung transplantation model / O. Yoshida [et al.] // Surg. Today. – 2013. – Vol. 43, N 1. – P. 81–87.
7. Cellular electrophysiologic and mechanical evidence of superior vascular protection in pul-monarymicrocirculation by Perfadex compared with Celsior / M. Wu [et al.] // J. Thorac. Cardiovascular. Surg. – 2009. – Vol. 137, N 2. – P. 492–498.
8. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients / G. Warnecke [et al.] // Lancet. – 2012. – Vol. 380, N 9856. – P. 1851–1858.
9. Guidelines for the diagnosis and treatment of pulmonary hypertension / N. Galie [et al.] // Eur. Heart J. – 2009. – Vol. 30, N 20. – P. 2493–2537.
10. Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study / M.R. Wilkins [et al.] // Am. J. Resp. Crit. Care. – 2005. – Vol. 171, N 11. – P. 1292–1297.
11. Ex vivo rehabilitation of non-heartbeating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function / D.P. Mulloy [et al.] // J. Thorac. Cardiovasc. Surg. – 2012. – Vol. 144, N 5. – P. 1208–1215.
12. Ex vivo lung reconditioning: a new era for lung transplantation / A.W. Mariani, P.M. P go-Fernandes, L.G. Abdalla, F.B. Jatene // J. Bras. Pneumol. – 2012. – Vol. 38, N 6. – P. 776–785.
13. Transplantation of initially rejected donor lungs after ex vivo lung perfusion / A. Wallinder [et al.] // J. Thorac. Cardiovasc. Surg. – 2012. – Vol. 144, N 5. – P. 1222–1228.
14. First human transplantation of a nonacceptable donor lung afterreconditioning ex vivo / S. Steen [et al.] // Ann. Thorac. Surg. – 2007. – Vol. 83, N 6. – P. 2191–2194.
15. Experience with the first 50 ex vivo lung perfusions in clinical transplantation / M.J. Cypel [et al.] // Thorac. Cardiovasc Surg. – 2012. – Vol. 144, N 5. – P. 1200– 1206.
16. Comparison of lung preservation solutions in human lungs using an ex vivo lung perfusion experimental model / I.L. Medeiros [et al.] // Clinics (Sao Paulo). – 2012. – Vol. 67, N 9. – P. 1101–1106.
17. A new porcine model of reperfusion injury after lung transplantation /S.C. Clark [et al.] // Lab. Anim. – 1999. – Vol. 33, N 2. – P. 135–142.
18. A new model for the assessment of lung allograft ischemia/reperfusion injury / S. Hillinger [et al.] // J. Invest. Surg. – 2000.– Vol. 13, N 1. – P. 59–65.
19. Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcinelung transplantation model / D.J. LaPar [et al.] // J. Thorac. Cardiovasc. Surg. – 2011.– Vol. 142, N 4. – P. 887–894.
20. In vivo imaging of human pancreatic microcirculation and pancreatic tissue injury in clinical pancreas transplantation / K.D. Schaser [et al.] // Am. J. Transplant. – 2005. – Vol. 5, N 2. – P. 341–350.
21. In vivo visualization of early microcirculatory changes following ischemia/reperfusion injury in human kidney transplantation / V. Schmitz [et al.] // Eur Surg Res. – 2008. – Vol. 40, N 1. – P. 19–25.
22. An experimental approach toward chronic pulmonary allograft rejection: Orthotopic lung versus heterotopic tracheal segment transplantation in rats / W. Jungraithmayr [et al.] // Transplant. Proc. – 2010. – Vol. 42, N 7. – P. 2767–2770.
23. Wilkes, D.S. Chronic lung allograft rejection and airway microvasculature: is HIF-1 the missing link? / D.S. Wilkes // J. Clin. Invest. – 2011. – Vol. 121, N 6. – P. 2155–2157.
Рецензия
Для цитирования:
Яблонский П.К., Резник О.Н., Скворцов А.Е., Милехин В.Е. Влияние ингибиторов фосфодиэстеразы-5 на альвеолярный кровоток легочного трансплантата. Трансплантология. 2013;(3):28-33.
For citation:
Yablonskiy P.K., Reznik O.N., Skvortsov A.E., Milehin V.E. The effect of phosphodiesterase-5 inhibitors on the alveolar blood fl ow in the pulmonary graft. Transplantologiya. The Russian Journal of Transplantation. 2013;(3):28-33. (In Russ.)
Просмотров: 538
Послать статью по эл. почте 